Sickle Cell Pain: Intervention With Capsaicin Exposure
clinical trial
Press Enter · cited answer in seconds
0 sources
Summary
Sickle Cell Pain: Intervention With Capsaicin Exposure is a clinical trial[1].
Key Facts
- Sickle Cell Pain: Intervention With Capsaicin Exposure's instance of is recorded as Intervention With Capsaicin Exposure — instance of (P31): clinical trial[2].
- Sickle Cell Pain: Intervention With Capsaicin Exposure's start time is recorded as +2019-04-15T00:00:00Z[3].
- Sickle Cell Pain: Intervention With Capsaicin Exposure's end time is recorded as +2020-01-31T00:00:00Z[4].
- Sickle Cell Pain: Intervention With Capsaicin Exposure's sponsor is recorded as Intervention With Capsaicin Exposure — sponsor (P859): Children's Hospital of Michigan[5].
- Sickle Cell Pain: Intervention With Capsaicin Exposure's main subject is recorded as Intervention With Capsaicin Exposure — main subject (P921): pain[6].
- Sickle Cell Pain: Intervention With Capsaicin Exposure's number of participants is recorded as {'unit': '1', 'amount': '+10'}[7].
- Sickle Cell Pain: Intervention With Capsaicin Exposure's title is recorded as Safety and Feasibility of High-Dose Topical Capsaicin for the Treatment of Neuropathic Pain in Pediatric Sickle Cell Disease[8].
- Sickle Cell Pain: Intervention With Capsaicin Exposure's short name is recorded as SPICE[9].
- Sickle Cell Pain: Intervention With Capsaicin Exposure's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+14'}[10].
- Sickle Cell Pain: Intervention With Capsaicin Exposure's ClinicalTrials.gov ID is recorded as NCT03899246[11].
- Sickle Cell Pain: Intervention With Capsaicin Exposure's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+21'}[12].
- Sickle Cell Pain: Intervention With Capsaicin Exposure's research intervention is recorded as Intervention With Capsaicin Exposure — research intervention (P4844): capsaicin[13].
- Sickle Cell Pain: Intervention With Capsaicin Exposure's clinical trial phase is recorded as Intervention With Capsaicin Exposure — clinical trial phase (P6099): phase I clinical trial[14].
- Sickle Cell Pain: Intervention With Capsaicin Exposure's research site is recorded as Intervention With Capsaicin Exposure — research site (P6153): Children's Hospital of Michigan[15].
- Sickle Cell Pain: Intervention With Capsaicin Exposure's study type is recorded as Intervention With Capsaicin Exposure — study type (P8363): interventional study[16].